Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;29(11):958-967.
doi: 10.1111/jvh.13733. Epub 2022 Aug 24.

Anti-HBc-nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults

Affiliations

Anti-HBc-nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults

Xuelian Deng et al. J Viral Hepat. 2022 Nov.

Abstract

Absence of anti-HBc reactivity with detectable anti-HBs was observed in blood donors with occult hepatitis B virus (HBV) infection (OBI). The prevalence and mechanisms underlying this uncommon condition were investigated over time in Chinese blood donors with OBI. Isolated anti-HBs OBI status was identified from 466,911 donors from Dalian, China, and monitored in follow-up (range: 2.6-84.3 months). HBV vaccination status was documented, and infecting viral strains were characterized. Of 451 confirmed OBIs (1:1035), 43 (9.5%; 1:10,858) had isolated anti-HBs as only serological marker. Isolated anti-HBs OBIs differed from anti-HBc-reactive OBIs by significantly younger age (median 24 years), higher HBV DNA (median: 20 IU/ml) and anti-HBs (median 60.5 IU/L) levels, paucity of mutations in HBV Core and S proteins, and high vaccination rate (72%). Vaccinated isolated anti-HBs OBIs (n = 31) differed from unvaccinated (n = 11) by significantly younger age (22 vs 38 years), higher anti-HBs level at index (48% vs 9% with anti-HBs >100 IU/L) and higher frequency of anti-HBs immune response (44% vs 20%). Of 15 vaccinated and 5 unvaccinated OBIs follow-up, 65% (8 vaccinated and 5 unvaccinated) became HBV DNA negative suggesting aborted recent infection, while 35% (7 vaccinated) had low persistent viraemia 2 to 65 months post index. In conclusion, isolated anti-HBs OBI in Chinese blood donors appears associated with young, vaccinated, adults exposed to HBV who predominantly develop low level aborted infection revealed by transient HBV DNA and immune anti-HBs response. However, a subset of individuals still experienced low but persistent viral replication whose clinical outcome remains uncertain.

Keywords: HBV variants; anti-HBs; blood donors; hepatitis B vaccine; hepatitis B virus; occult infection; viral DNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Detection of HBV serological and molecular markers in pre‐qualified blood donors.
FIGURE 2
FIGURE 2
Anti‐HBs and HBV DNA detection over time in vaccinated and unvaccinated isolated anti‐HBs OBI carriers. Open symbols indicate undetectable HBV DNA. Arrows indicate anti‐HBc positive samples.
FIGURE 3
FIGURE 3
Correlation between age of OBI and HBsAg+ carriers and the level of amino acid mutation in viral Core and S proteins. Dots represent individual values. Red dots indicate isolated anti‐HBs OBIs. Spearman rank correlation test was used.

Similar articles

Cited by

References

    1. Raimondo G, Locarnini S, Pollicino T, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71:397‐408. - PubMed
    1. Lelie N, Bruhn R, Busch M, et al. Detection of different categories of hepatitis B virus (HBV) infection in a multi‐regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV‐DNA testing. Transfusion. 2017;57:24‐35. - PubMed
    1. Ni YH, Hsu HY, Chang MH, Chen DS, Lee CY. Absence or delayed appearance of hepatitis B core antibody in chronic hepatitis B surface antigen carrier children. J Hepatol. 1993;17:150‐154. - PubMed
    1. Zoulim F, Zhang X, Pichoud C, Trepo C. Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV‐associated cirrhosis and serum negativity for anti‐HBc. J Hepatol. 1996;24:155‐160. - PubMed
    1. Kantelhardt VC, Schwarz A, Wend U, et al. Re‐evaluation of anti‐HBc non‐reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen. J Clin Virol. 2009;46:124‐128. - PubMed

Publication types